1-20 of 63
Robert F. Sidonio, Jr
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Continuous Prophylaxis with Recombinant Von Willebrand Factor in People with Clinically Severe Congenital Types 1 and 2 Von Willebrand Disease in a Real-World Setting: Interim Analysis of Athn 9, a Natural History Study for People with Severe VWD

Robert F Sidonio, Jr., Angela C Weyand, Tammuella Chrisentery-Singleton, Martin Chandler, Carol Fedor, Priscilla Driscoll-Shempp, Michelle Kirby, Jorge Caicedo
Journal: Blood
Blood (2024) 144 (Supplement 1): 2594.
https://doi.org/10.1182/blood-2024-200261
Published: 2024
Journal Articles

Diagnosis and Disease Burden of Von Willebrand Disease in a Large US Population Based-Dataset

Michelle Sholzberg, Angela C Weyand, Jacob S Lai, Benjamin Kim, Gary Patou, Nicole M. Engel-Nitz, Qiana Amos, Robert F. Sidonio, Jr.
Journal: Blood
Blood (2024) 144 (Supplement 1): 3980.
https://doi.org/10.1182/blood-2024-206631
Published: 2024
Journal Articles

Disparities in Real-World Treatment Patterns Among Patients with Von Willebrand Disease in a Large US Population-Based Dataset

Angela C Weyand, Michelle Sholzberg, Jacob S Lai, Benjamin Kim, Adam Rosenthal, Scott M Robertson, Gary Patou, Robert F. Sidonio, Jr.
Journal: Blood
Blood (2024) 144 (Supplement 1): 3978.
https://doi.org/10.1182/blood-2024-206567
Published: 2024
Journal Articles

Development of a Working Definition of Severe Von Willebrand Disease

Tung Wynn, Christopher Walsh, Jeanette Cesta, Robert F Sidonio, Jr., Stefanie Dugan, Mona Sayedul Huq
Journal: Blood
Blood (2024) 144 (Supplement 1): 5019.
https://doi.org/10.1182/blood-2024-208188
Published: 2024
Journal Articles

Immune Toleration Induction with Emicizumab in Hemophilia a Patients with Inhibitors: A Systematic Review

Prashant Raghavendran, Robert F Sidonio, Jr., Glaivy Batsuli
Journal: Blood
Blood (2024) 144 (Supplement 1): 1206.
https://doi.org/10.1182/blood-2024-207335
Published: 2024
Journal Articles

Efficacy and Safety of Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate Among Von Willebrand Disease Patients across All ABO Antigen Blood Groups

Robert F. Sidonio, Jr.
Journal: Blood
Blood (2024) 144 (Supplement 1): 3985.
https://doi.org/10.1182/blood-2024-194448
Published: 2024
Journal Articles

Increased Prophylactic Dosing Frequency Effectively Improve Bleeding Rates in Von Willebrand Disease Patients Who Require Higher Hemostatic Coverage - a Sub-Analysis of Data from the Wil-31 Study

Robert F Sidonio, Jr.
Journal: Blood
Blood (2024) 144 (Supplement 1): 5498.
https://doi.org/10.1182/blood-2024-193886
Published: 2024
Journal Articles

Strategies for Immune Tolerance Induction in Hemophilia a Patients with Inhibitors: The First Prespecified Interim Analysis from the Motivate Study

Carmen Escuriola, Robert F. Sidonio, Jr.
Journal: Blood
Blood (2024) 144 (Supplement 1): 5475.
https://doi.org/10.1182/blood-2024-193874
Published: 2024
Journal Articles

RNAing toward a new therapy for hemophilia

Clinical Trials & Observations
Bhavya S. Doshi, Robert F. Sidonio, Jr
Journal: Blood
Blood (2024) 143 (22): 2219–2221.
https://doi.org/10.1182/blood.2024024295
Published: 2024
Journal Articles

Design of an Observational Study (PROVE) to Assess the Long-Term Effects of Prophylaxis with Simoctocog Alfa or Emicizumab on Joint and Bone Health in Hemophilia a Patients

Robert Klamroth, Robert F Sidonio, Jr., Yesim Dargaud, Víctor Jiménez-Yuste, Rolf Ljung, Guy Young, Pratima Chowdary
Journal: Blood
Blood (2023) 142 (Supplement 1): 1255.
https://doi.org/10.1182/blood-2023-181725
Published: 2023
Journal Articles

Efficacy and Safety of Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate in Children and Adolescents with Von Willebrand Disease - a Sub-Analysis of Data from the Wil-31 Study

Robert F Sidonio, Jr., Leonid Dubey, Kateryna V Vilchevska, Adlette Inati, Claudia Djambas Khayat
Journal: Blood
Blood (2023) 142 (Supplement 1): 3992.
https://doi.org/10.1182/blood-2023-180513
Published: 2023
Journal Articles

Efficacy of Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate in Reducing Nose Bleeds in Children and Adults with Von Willebrand Disease

Ana Boban, Robert F Sidonio, Jr., Leonid Dubey, Kateryna V Vilchevska, Adlette Inati, Claudia Djambas Khayat
Journal: Blood
Blood (2023) 142 (Supplement 1): 5509.
https://doi.org/10.1182/blood-2023-180029
Published: 2023
Journal Articles

Efficacy of Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate in Reducing Heavy Menstrual Bleeding in Females with Von Willebrand Disease

Csongor Kiss, Zoltan Boda, Claudia Djambas Khayat, Leonid Dubey, Robert F Sidonio, Jr.
Journal: Blood
Blood (2023) 142 (Supplement 1): 3997.
https://doi.org/10.1182/blood-2023-180498
Published: 2023
Journal Articles

Effect of Factor VIII and Von Willebrand Factor Activities on Number of Bleeding Events in Previously Treated Patients with Von Willebrand Disease on Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate

Kateryna V Vilchevska, Vladimir Vdovin, Margarita Timofeeva, Claudia Djambas Khayat, Adlette Inati, Robert F Sidonio, Jr.
Journal: Blood
Blood (2023) 142 (Supplement 1): 5510.
https://doi.org/10.1182/blood-2023-180526
Published: 2023
Journal Articles

Immunogenicity of a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate during the Wil-31 Prophylaxis Study in Patients with Von Willebrand Disease

Claudia Djambas Khayat, Robert F Sidonio, Jr., Anna Pavlova
Journal: Blood
Blood (2023) 142 (Supplement 1): 5485.
https://doi.org/10.1182/blood-2023-180585
Published: 2023
Journal Articles

Performance of the Comprehensive Assessment Tool for Challenges in Hemophilia (CATCH) 2.0

Marquita Decker-Palmer, Susan Mathias, Hilary Colwell, Ross Crosby, Brittany Gentile, Janet Chupka, Robert F. Sidonio, Jr., Michael Recht, Amy D. Shapiro, James Zazzali
Journal: Blood
Blood (2022) 140 (Supplement 1): 11328–11329.
https://doi.org/10.1182/blood-2022-157932
Published: 2022
Journal Articles

U.S. Cohort Study of Previously Untreated Patients with Congenital Hemophilia (ATHN 8: PUPs Study): Inhibitor Development and Treatment Characteristics

Shannon L Carpenter, Martin Chandler, Michael F Guerrera, Lynn Malec, Matthew Manuel, Michael Recht, Ulrike Reiss, Robert F. Sidonio, Jr., Cristina Tarango, Marijke Van den Berg, Michael Wang, Courtney D. Thornburg
Journal: Blood
Blood (2022) 140 (Supplement 1): 63–64.
https://doi.org/10.1182/blood-2022-162660
Published: 2022
Journal Articles

Assessment of Menstrual Health and Bleeding Symptoms in Adolescent Girls and Young Women with Sickle Cell Disease

Brittany Notice, Elizabeth Soffer, Yijin Xiang, Kelly Tickle, Beatrice E Gee, Robert F. Sidonio, Jr., Glaivy Batsuli
Journal: Blood
Blood (2022) 140 (Supplement 1): 5116–5118.
https://doi.org/10.1182/blood-2022-167857
Published: 2022
Journal Articles

Multicenter, Randomized Crossover Trial Comparing Recombinant Von Willebrand Factor and Tranexamic Acid for Heavy Menstrual Bleeding in Von Willebrand Disease

Margaret V. Ragni, Scott Rothenberger, Robert Feldman, Danielle Nance, Andrew D Leavitt, Lynn Malec, Robert F. Sidonio, Jr., Eric H. Kraut, Joseph L Lasky, III, Claire S. Philipp, Dana E. Angelini, Rajiv K. Pruthi, Nina Hwang, Allison P. Wheeler, Roshni Kulkarni, Craig D. Seaman, Frederico Xavier, Nicoletta C Machin, Michael Meyer, Daniel Bellissimo, Kenneth J. Smith, Elizabeth P. Merricks, Timothy C. Nichols, Dana Ivanco, Deborah Vehec, Glory Koerbel, Andrew D. Althouse
Journal: Blood
Blood (2022) 140 (Supplement 1): 1413–1415.
https://doi.org/10.1182/blood-2022-156921
Published: 2022
Journal Articles

Clinical Characteristics Impacting Health-Related Quality of Life in Persons with Von Willebrand Disease

Shannon L Carpenter, Joanne Wu, Jonathan C. Roberts, Roshni Kulkarni, Peter A. Kouides, Robert F. Sidonio, Jr., Barbara Konkle, Judith Baker, Megan M. Ullman, Randall Curtis, Nicole Crook, Michael B. Nichol
Journal: Blood
Blood (2022) 140 (Supplement 1): 5127–5128.
https://doi.org/10.1182/blood-2022-160463
Published: 2022